Acrivon TherapeuticsACRV
那斯達克 · USD
1.26
-0.02
(-1.56%)
收盤 08/02 03:41 (UTC+8)
盤後
0
0
(0%)
08/02 03:41 (UTC+8)
Acrivon TherapeuticsACRV
1.26
-0.02
(-1.56%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 21,662 | - | - | 21,437 | - | 21,053 | 16,137 | 15,520 | 14,393 | 9,945 |
研發費用 | 15,414 | 18,630 | 18,864 | 15,025 | 11,473 | 15,478 | 10,267 | 10,521 | 9,758 | 5,862 |
推銷及管理費用 | 6,248 | 6,324 | 6,276 | 6,412 | 6,195 | 5,575 | 5,870 | 4,999 | 4,635 | 4,083 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -21,662 | -24,954 | -25,140 | -21,437 | -17,668 | -21,053 | -16,137 | -15,520 | -14,393 | -9,945 |
其他收入及費用 | 1,982 | 2,123 | 2,699 | 2,639 | 1,182 | 1,801 | 1,671 | 1,606 | 1,637 | 1,016 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -19,680 | -22,831 | -22,441 | -18,798 | -16,486 | -19,252 | -14,466 | -13,914 | -12,756 | -8,929 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -19,680 | -22,831 | -22,441 | -18,798 | -16,486 | -19,252 | -14,466 | -13,914 | -12,756 | -8,929 |
基本每股稅後盈餘(元) | -0.51 | -0.60 | -0.59 | -0.52 | -0.73 | - | -0.66 | -0.63 | -0.58 | -0.80 |
稀釋每股稅後盈餘(元) | -0.51 | -0.59 | -0.59 | -0.47 | -0.73 | -0.87 | -0.65 | -0.64 | -0.58 | 4.99 |
基本平均股數(千股) | 38350.00 | 38242.00 | 38105.00 | 36132.00 | 22590.00 | - | 22081.00 | 21971.00 | 21920.00 | 11093.00 |
稀釋平均股數(千股) | 38350.00 | 38242.00 | 38105.00 | 36132.00 | 22590.00 | - | 22081.00 | 21971.00 | 21920.00 | 11093.00 |
還原基本每股稅後盈餘(元) | -0.51 | -0.60 | -0.59 | -0.52 | -0.73 | - | -0.66 | -0.63 | -0.58 | -0.80 |
還原稀釋每股稅後盈餘(元) | -0.51 | -0.59 | -0.59 | -0.47 | -0.73 | -0.87 | -0.65 | -0.64 | -0.58 | 4.99 |
還原基本平均股數(千股) | 38,350 | 38,242 | 38,105 | 36,132 | 22,590 | - | 22,081 | 21,971 | 21,920 | 11,093 |
還原稀釋平均股數(千股) | 38,350 | 38,242 | 38,105 | 36,132 | 22,590 | - | 22,081 | 21,971 | 21,920 | 11,093 |
EBITDA(千元) | -19,729 | -23,425 | -23,394 | -19,669 | -16,839 | -19,783 | -15,075 | -14,553 | -13,764 | -9,320 |